An early report looking at the peripheral blood and marrow of AML patients showed that null definition ILC1s (Lin-CD56-CD127+CRTH2-CD117-) are enriched and hypofunctional compared to healthy donors [32]. This evidence concerns the gene KIT and acute myeloid leukemia.